HomeAI · summaries
Storia in 2 fonti
Novartis and Orionis strike second molecular glue deal for $40M upfront
Novartis inks second molecular glue deal with Orionis Biosciences, paying $40M upfront and up to $1.4B in milestones across multiple disease areas.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
- ·
endpoints.news
Novartis and Orionis strike second molecular glue deal for $40M upfront
Novartis inks second molecular glue deal with Orionis Biosciences, paying $40M upfront and up to $1.4B in milestones across multiple disease areas.